← Back to Search

Neuromuscular Electrical Stimulation

Active NMES + Swallowing Exercise for Swallowing Difficulty

N/A
Waitlist Available
Led By Susan Langmore, PhD,SLP,BRS
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after treatment

Summary

The purpose of the investigation is to learn whether intense swallowing exercise or intense swallowing exercise coupled with electrical stimulation (E-Stim) helps patients who had head/neck cancer and currently have dysphagia swallow better.

Eligible Conditions
  • Swallowing Difficulty

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Penetration-Aspiration Scale (PAS) Score
Secondary study objectives
Performance Status Scale for Head and Neck Cancer Patients (PSS); The Head and Neck Cancer Inventory (HNCI)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active NMES + Swallowing ExerciseActive Control1 Intervention
Active Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES) therapy will be paired concomitantly with repeated effortful sallowing exercises, for 60 swallows, 2 times per day, 6 days per week, for 12 weeks.
Group II: Sham NMES + Swallowing ExercisePlacebo Group1 Intervention
Sham (inactive) Neurotech NT2000 Neuromuscular Electrical Stimulation (NMES) therapy will be paired concomitantly with repeated effortful sallowing exercises, for 60 swallows, 2 times per day, 6 days per week, for 12 weeks.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,937 Previous Clinical Trials
41,022,207 Total Patients Enrolled
Boston Medical CenterLead Sponsor
402 Previous Clinical Trials
883,725 Total Patients Enrolled
Northwestern UniversityOTHER
1,649 Previous Clinical Trials
958,508 Total Patients Enrolled
~10 spots leftby Dec 2025